REQUEST A DEMO
Total
USD $0.00
Search more companies

Galepharma Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Galepharma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Galepharma Ilac A.S. is an enterprise located in Turkiye, with the main office in Istanbul. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It currently has a total number of 101 - 500 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 53.95% in 2020. Its total assets grew by 41.86% over the same period. Galepharma Ilac A.S.’s net profit margin increased by 0.63% in 2020.

Headquarters
No:7a Sarigazi Mahallesi Karagoz Sokak Sancaktepe
Istanbul; Marmara;

Contact Details: Purchase the Galepharma Ilac A.S. report to view the information.

Website: http://galepharma.com.tr

Basic Information
Total Employees:
Purchase the Galepharma Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Galepharma Ilac A.S. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Galepharma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
53.95%
Total operating revenue
53.95%
Operating profit (EBIT)
84.18%
Net Profit (Loss) for the Period
24.54%
Total assets
41.86%
Total equity
-12.91%
Operating Profit Margin (ROS)
1.67%
Net Profit Margin
0.63%
Return on Equity (ROE)
1.5%
Debt to Equity Ratio
600.17%
Quick Ratio
1.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?